Guizhou Bailing Group Pharmaceutical Co Ltd (002424) - Total Liabilities

Latest as of March 2026: CN¥2.75 Billion CNY ≈ $402.83 Million USD

Based on the latest financial reports, Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has total liabilities worth CN¥2.75 Billion CNY (≈ $402.83 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Guizhou Bailing Group Pharmaceutical Co (002424) equity growth momentum to track the company's year-over-year net asset growth rate.

Guizhou Bailing Group Pharmaceutical Co Ltd - Total Liabilities Trend (2007–2025)

This chart illustrates how Guizhou Bailing Group Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 002424 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Guizhou Bailing Group Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Guizhou Bailing Group Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Sedlmayr Grund und Immobilien AG F:SPB	Germany	€980.61 Million
Harbin Gloria Pharmaceuticals SHE:002437	China	CN¥735.96 Million
Grindrod JSE:GND	South Africa	ZAC6.16 Billion
Medartis Holding AG SW:MED	Switzerland	CHF284.05 Million
Sichuan Crun Co Ltd SHE:002272	China	CN¥2.11 Billion
INVEX Controladora S.A.B. de C.V MX:INVEXA	Mexico	MX$220.57 Billion
Summit TA:SMT	Israel	ILA5.48 Billion
Karelia Tobacco Company Inc AT:KARE	Greece	€173.12 Million

Liability Composition Analysis (2007–2025)

This chart breaks down Guizhou Bailing Group Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Guizhou Bailing Group Pharmaceutical Co (002424) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.95	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.86	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.46	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Guizhou Bailing Group Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Guizhou Bailing Group Pharmaceutical Co Ltd (2007–2025)

The table below shows the annual total liabilities of Guizhou Bailing Group Pharmaceutical Co Ltd from 2007 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥3.02 Billion ≈ $442.32 Million	-23.20%
2024-12-31	CN¥3.94 Billion ≈ $575.92 Million	+2.98%
2023-12-31	CN¥3.82 Billion ≈ $559.25 Million	+31.90%
2022-12-31	CN¥2.90 Billion ≈ $423.99 Million	+14.56%
2021-12-31	CN¥2.53 Billion ≈ $370.09 Million	-18.74%
2020-12-31	CN¥3.11 Billion ≈ $455.46 Million	+6.86%
2019-12-31	CN¥2.91 Billion ≈ $426.23 Million	+41.98%
2018-12-31	CN¥2.05 Billion ≈ $300.21 Million	+51.35%
2017-12-31	CN¥1.36 Billion ≈ $198.35 Million	+15.79%
2016-12-31	CN¥1.17 Billion ≈ $171.30 Million	+0.87%
2015-12-31	CN¥1.16 Billion ≈ $169.82 Million	-4.66%
2014-12-31	CN¥1.22 Billion ≈ $178.13 Million	-9.95%
2013-12-31	CN¥1.35 Billion ≈ $197.81 Million	+12.89%
2012-12-31	CN¥1.20 Billion ≈ $175.23 Million	+11.04%
2011-12-31	CN¥1.08 Billion ≈ $157.81 Million	+13.22%
2010-12-31	CN¥952.49 Million ≈ $139.38 Million	+113.81%
2009-12-31	CN¥445.48 Million ≈ $65.19 Million	+38.90%
2008-12-31	CN¥320.72 Million ≈ $46.93 Million	+1.54%
2007-12-31	CN¥315.87 Million ≈ $46.22 Million	--

About Guizhou Bailing Group Pharmaceutical Co Ltd

SHE:002424 China Drug Manufacturers - Specialty & Generic

Market Cap

$938.71 Million

CN¥6.41 Billion CNY

Market Cap Rank

#9074 Global

#2205 in China

Share Price

CN¥4.59

Change (1 day)

-0.22%

52-Week Range

CN¥4.09 - CN¥6.29

All Time High

CN¥28.52